Interleukin-6(2)/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies

In a convenience sample of 93 patients treated with monoclonal antibodies (moAbs) against SARS-CoV-2, the interleukin-6(2)/lymphocyte count ratio (IL-6(2)/LC) was able to predict clinical worsening both in early stages of COVID-19 and in oxygen-requiring patients. Moreover, we analysed 18 most at-ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotundo, Salvatore, Borelli, Massimo, Scaglione, Vincenzo, Lionello, Rosaria, Biamonte, Flavia, Olivadese, Vincenzo, Quirino, Angela, Morrone, Helen Linda, Matera, Giovanni, Costanzo, Francesco Saverio, Russo, Alessandro, Trecarichi, Enrico Maria, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127195/
https://www.ncbi.nlm.nih.gov/pubmed/37097384
http://dx.doi.org/10.1007/s10238-023-01081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127195/
https://www.ncbi.nlm.nih.gov/pubmed/37097384
http://dx.doi.org/10.1007/s10238-023-01081-6

Ejemplares similares